Oclorus™Spermidine Supplement
  • Home
  • Fisetin
  • Dasatinib-Quercetin
  • Navitoclax (ABT-263)
  • UBX1325
  • More
    • Home
    • Fisetin
    • Dasatinib-Quercetin
    • Navitoclax (ABT-263)
    • UBX1325
Oclorus™Spermidine Supplement
  • Home
  • Fisetin
  • Dasatinib-Quercetin
  • Navitoclax (ABT-263)
  • UBX1325

Mitora™17-DMAG–Premium HSP90 Inhibitor for Labs&B2B

<img src="17-dmag.jpg" alt="Mitora™ 17-DMAG HSP90 inhibitor for research use">

Research-Grade 17-DMAG–HSP90 Inhibitor for Bulk Orders

Mitora™17-DMAG is a high-purity HSP90 inhibitor and research-grade senolytic compound, widely used in cellular senescence, oncology, and protein homeostasis studies. 17-DMAG selectively inhibits HSP90 chaperone proteins, promoting senescent cell clearance and apoptosis in preclinical models. Our product is designed for B2B distributors, research laboratories, and academic institutions, ensuring reliable and reproducible results. 

Key Features

  • High Purity: ≥99% pure 17-DMAG for consistent and reproducible research results.
     
  • Research-Grade Quality: Ideal for in vitro studies, senolytic research, and preclinical experiments.
     
  • Bulk Supply Options: Flexible quantities available for B2B distributors, laboratories, and biotech companies.
     
  • Certificate of Analysis (COA): Each batch includes a COA confirming purity and identity.
     
  • Senolytic Applications: Widely used in senescent cell clearance studies, HSP90 pathway research, and drug discovery.

Technical Specifications

  • Chemical Name: 17-DMAG
     
  • CAS Number: 122335-83-6
     
  • Appearance: Yellow to orange crystalline powder
     
  • Purity: ≥99%
     
  • Storage: Store in a cool, dry place, protected from light

Why Choose Mitora™17-DMAG?

As a trusted senolytic compound supplier, Mitora™provides 17-DMAG – Premium HSP90 Inhibitor in bulk to research teams and distributors worldwide. Our rigorous quality control, consistent production, and international shipping ensure researchers have access to high-quality compounds for critical studies.

  • Preferred by academic laboratories, pharmaceutical R&D teams, and global B2B distributors.
     
  • Fully compliant with research use only (RUO) regulations.
     
  • Securely packaged for safe international transport.


Copyright©2023 Mitora™

Powered by Mitora™

  • Cardiac glycosides
  • Navitoclax-ABT-263
  • Ouabain–Cardiac Glycoside
  • Piperlongumine
  • 17-DMAG–HSP90 Inhibitor
  • Quality & Technology
  • About Us
  • Terms of Service
  • Privacy Policy
  • FAQ
  • Contact Us
  • Senolytic Compound News
  • Equal Opportunity
  • Legal Disclaimer–Mitora™
  • Health & Safety–Mitora™
  • Accessibility Statement

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept